Skip to content

Cancer Survivors' Fear of Cancer Recurrence

Development and Evaluation of An Innovative Program in Mental Health Promotion

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07542821
Acronym
MHPII
Enrollment
150
Registered
2026-04-21
Start date
2026-04-15
Completion date
2028-11-30
Last updated
2026-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fear of Cacer Recurrence in Cancer Survivorws

Keywords

Fear of cancer recurrence, cancer survivor, psychosoical support, ConquerFear, Healthy life style

Brief summary

The purpose of this study is to develop and evaluate the tailored support for the fear of cancer recurrence in breast, head and neck, colon-rectal or prostate cancer survivors. Based on screening for fear of cancer recurrence, different levels of supportive care will be provided, starting with the oncology nurses' health education and information for those having a lower level of concern. Those who have medium or higher levels of concerns will be randomized to receive "stepping up" either a "ConquerFear psychological cognitive training" or a "healthy lifestyle - individualized exercise and nutrition guidance".

Interventions

BEHAVIORALpsycological cognitive training

Metacognition

BEHAVIORALHealthy lifestyle

individualized nutrition and exercise guidance

BEHAVIORALeducation

FCR education

Sponsors

National Taipei University of Nursing and Health Sciences
Lead SponsorOTHER
Ministry of Health and Welfare, Taiwan
CollaboratorOTHER_GOV
Koo Foundation Sun Yat-Sen Cancer Center
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Based on screening levels of fear of cancer recurrence (FCR), those with lower FCR will receive only education, and those with medium or higher FCR will be randomized to one of two add-on psychological cognitive training or individualized healthy lifestyle guidance groups in parallel for the duration of the study.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* stage I, II, III breast, head and neck, colo-rectal, proste cancer and completion of primary cancer treatment * report of fear of cancer recurrence * able to read and listen in Manderin and without a cognitive defect

Exclusion criteria

* diagnosed with severe mental illness * difficult to communicate in Manderin

Design outcomes

Primary

MeasureTime frameDescription
Fear of Cance RecurrenceFrom the baseline to the 3 months after intervention at 5 monthsthe change of FCR (Fear of Cancer Recurrence) score as measured by FCRI

Secondary

MeasureTime frameDescription
Psychological distressFrom the baseline to the 3 months after intervention at 5 monthsthe change of the anxiety and depression as measured by HADS
QOLFrom the baseline to the 3 months after intervention at 5 monthsThe change of the quality of life score as measured by VR-12

Contacts

CONTACTShiuyu C. Katie Lee
shiuyu@ntunhs.edu.tw886961395150
CONTACTShiao-Wei Cheng
study1042@ntunhs.edu.tw886919885149
PRINCIPAL_INVESTIGATORShiuyu C. Katie Lee, PhD

National Taipei University of Nursing and Health Science

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 22, 2026